Literature DB >> 20035743

Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis--ongoing inflammation and an imbalance of the matrix degrading system.

Susanne Rutschow1, Sebastian Leschka, Dirk Westermann, Kerstin Puhl, Anneke Weitz, Leonid Ladyszenskij, Sebastian Jaeger, Heinz Zeichhardt, Michel Noutsias, Heinz-Peter Schultheiss, Carsten Tschope, Matthias Pauschinger.   

Abstract

Enteroviruses, especially Coxsackie B3 virus (CVB-3), cause acute viral myocarditis, but the detailed mechanisms leading to chronic left ventricular dysfunction and dilatation remain elusive. Myocardial tissues of CVB-3 infected and sham infected male swr/J mice were analyzed after hemodynamic evaluation on days 4, 7, and 28 p.i. by RT-PCR, gelatin zymography, ELISA, immunohistochemistry, sirius red staining, and luxol fast blue staining. In the early phase after infection an abnormal diastolic function was the main hemodynamic finding. CVB-3 infection caused impairment of left ventricular function combined with ventricular dilatation 7 and 28days post-infection. These hemodynamic findings were associated with relevant upregulation of different cytokines (IL-1beta, IL-6, IL-10, INF-gamma, and TNF-alpha) in the acute phase with persistent over-expression of IL-6, IL-10, and INF-gamma in the chronic phase. This virus induced myocardial inflammation was linked to a significant induced MMP/TIMP system (MMP-2,-3,-8, TIMP-1, uPA, tPA-mRNA expression, and MMP-2-activity) in the acute and chronic phase leading to imbalance in the MMP/TIMP-ratio at day 28. This imbalance in the MMP/TIMP system was significantly correlated to the development of ventricular dilatation. Viral persistence induces chronic myocardial inflammation and an imbalance of the matrix degrading system, associated with the development of left ventricular dysfunction and dilatation in chronic murine myocarditis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035743     DOI: 10.1016/j.ejphar.2009.12.019

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Evaluation of myelin sheath and collagen reorganization pattern in a model of peripheral nerve regeneration using an integrated histochemical approach.

Authors:  Víctor Carriel; Ingrid Garzón; Miguel Alaminos; Antonio Campos
Journal:  Histochem Cell Biol       Date:  2011-10-29       Impact factor: 4.304

Review 2.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 3.  Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.

Authors:  Reid G Hendry; Leanne M Bilawchuk; David J Marchant
Journal:  J Cardiovasc Transl Res       Date:  2014-01-01       Impact factor: 4.132

4.  [68Ga]-albumin-PET in the monitoring of left ventricular function in murine models of ischemic and dilated cardiomyopathy: comparison with cardiac MRI.

Authors:  Andrei Todica; Stefan Brunner; Guido Böning; Sebastian Lehner; Stephan G Nekolla; Moritz Wildgruber; Christopher Übleis; Carmen Wängler; Martina Sauter; Karin Klingel; Paul Cumming; Peter Bartenstein; Ralf Schirrmacher; Wolfgang Michael Franz; Marcus Hacker
Journal:  Mol Imaging Biol       Date:  2013-08       Impact factor: 3.488

5.  Mast cell inhibition attenuates myocardial damage, adverse remodeling, and dysfunction during fulminant myocarditis in the rat.

Authors:  Yair Mina; Shunit Rinkevich-Shop; Eli Konen; Orly Goitein; Tammar Kushnir; Frederick H Epstein; Micha S Feinberg; Jonathan Leor; Natalie Landa-Rouben
Journal:  J Cardiovasc Pharmacol Ther       Date:  2012-11-19       Impact factor: 2.457

6.  The Protective Effects of Ivabradine in Preventing Progression from Viral Myocarditis to Dilated Cardiomyopathy.

Authors:  Li Yue-Chun; Chen Guang-Yi; Ge Li-Sha; Xing Chao; Tian Xinqiao; Lin Cong; Dai Xiao-Ya; Yang Xiangjun
Journal:  Front Pharmacol       Date:  2016-11-01       Impact factor: 5.810

7.  Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis.

Authors:  Carsten Tschöpe; Sophie Van Linthout; Sebastian Jäger; Robert Arndt; Tobias Trippel; Irene Müller; Ahmed Elsanhoury; Susanne Rutschow; Stefan D Anker; Heinz-Peter Schultheiss; Matthias Pauschinger; Frank Spillmann; Kathleen Pappritz
Journal:  ESC Heart Fail       Date:  2020-07-14

8.  Left ventricular functional assessment in murine models of ischemic and dilated cardiomyopathy using [18 F]FDG-PET: comparison with cardiac MRI and monitoring erythropoietin therapy.

Authors:  Stefan Brunner; Andrei Todica; Guido Böning; Stefan G Nekolla; Moritz Wildgruber; Sebastian Lehner; Martina Sauter; Christopher Ubleis; Karin Klingel; Paul Cumming; Wolfgang Michael Franz; Marcus Hacker
Journal:  EJNMMI Res       Date:  2012-08-03       Impact factor: 3.138

9.  The role of 1.5 tesla MRI and anesthetic regimen concerning cardiac analysis in mice with cardiomyopathy.

Authors:  Ulrich Grabmaier; Hans D Theiss; Alexandra Keithahn; Julia Kreiner; Christoph Brenner; Bruno Huber; Christine von der Helm; Lisa Gross; Karin Klingel; Wolfgang-M Franz; Stefan Brunner
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

10.  α-Gal immunization positively impacts Trypanosoma cruzi colonization of heart tissue in a mouse model.

Authors:  Gisele Macêdo Rodrigues da Cunha; Maíra Araújo Azevedo; Denise Silva Nogueira; Marianna de Carvalho Clímaco; Edward Valencia Ayala; Juan Atilio Jimenez Chunga; Raul Jesus Ynocente La Valle; Lucia Maria da Cunha Galvão; Egler Chiari; Carlos Ramon Nascimento Brito; Rodrigo Pedro Soares; Paula Monalisa Nogueira; Ricardo Toshio Fujiwara; Ricardo Gazzinelli; Robert Hincapie; Carlos-Sanhueza Chaves; Fabricio Marcus Silva Oliveira; M G Finn; Alexandre Ferreira Marques
Journal:  PLoS Negl Trop Dis       Date:  2021-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.